Cargando…
A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We presen...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501040/ https://www.ncbi.nlm.nih.gov/pubmed/34625656 http://dx.doi.org/10.1038/s41746-021-00511-7 |
_version_ | 1784580566961618944 |
---|---|
author | Arık, Sercan Ö. Shor, Joel Sinha, Rajarishi Yoon, Jinsung Ledsam, Joseph R. Le, Long T. Dusenberry, Michael W. Yoder, Nathanael C. Popendorf, Kris Epshteyn, Arkady Euphrosine, Johan Kanal, Elli Jones, Isaac Li, Chun-Liang Luan, Beth Mckenna, Joe Menon, Vikas Singh, Shashank Sun, Mimi Ravi, Ashwin Sura Zhang, Leyou Sava, Dario Cunningham, Kane Kayama, Hiroki Tsai, Thomas Yoneoka, Daisuke Nomura, Shuhei Miyata, Hiroaki Pfister, Tomas |
author_facet | Arık, Sercan Ö. Shor, Joel Sinha, Rajarishi Yoon, Jinsung Ledsam, Joseph R. Le, Long T. Dusenberry, Michael W. Yoder, Nathanael C. Popendorf, Kris Epshteyn, Arkady Euphrosine, Johan Kanal, Elli Jones, Isaac Li, Chun-Liang Luan, Beth Mckenna, Joe Menon, Vikas Singh, Shashank Sun, Mimi Ravi, Ashwin Sura Zhang, Leyou Sava, Dario Cunningham, Kane Kayama, Hiroki Tsai, Thomas Yoneoka, Daisuke Nomura, Shuhei Miyata, Hiroaki Pfister, Tomas |
author_sort | Arık, Sercan Ö. |
collection | PubMed |
description | The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently <8% (US) and <29% (Japan), while cumulative MAPE remained <2% (US) and <10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions. |
format | Online Article Text |
id | pubmed-8501040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85010402021-10-22 A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan Arık, Sercan Ö. Shor, Joel Sinha, Rajarishi Yoon, Jinsung Ledsam, Joseph R. Le, Long T. Dusenberry, Michael W. Yoder, Nathanael C. Popendorf, Kris Epshteyn, Arkady Euphrosine, Johan Kanal, Elli Jones, Isaac Li, Chun-Liang Luan, Beth Mckenna, Joe Menon, Vikas Singh, Shashank Sun, Mimi Ravi, Ashwin Sura Zhang, Leyou Sava, Dario Cunningham, Kane Kayama, Hiroki Tsai, Thomas Yoneoka, Daisuke Nomura, Shuhei Miyata, Hiroaki Pfister, Tomas NPJ Digit Med Article The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently <8% (US) and <29% (Japan), while cumulative MAPE remained <2% (US) and <10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions. Nature Publishing Group UK 2021-10-08 /pmc/articles/PMC8501040/ /pubmed/34625656 http://dx.doi.org/10.1038/s41746-021-00511-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Arık, Sercan Ö. Shor, Joel Sinha, Rajarishi Yoon, Jinsung Ledsam, Joseph R. Le, Long T. Dusenberry, Michael W. Yoder, Nathanael C. Popendorf, Kris Epshteyn, Arkady Euphrosine, Johan Kanal, Elli Jones, Isaac Li, Chun-Liang Luan, Beth Mckenna, Joe Menon, Vikas Singh, Shashank Sun, Mimi Ravi, Ashwin Sura Zhang, Leyou Sava, Dario Cunningham, Kane Kayama, Hiroki Tsai, Thomas Yoneoka, Daisuke Nomura, Shuhei Miyata, Hiroaki Pfister, Tomas A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan |
title | A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan |
title_full | A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan |
title_fullStr | A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan |
title_full_unstemmed | A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan |
title_short | A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan |
title_sort | prospective evaluation of ai-augmented epidemiology to forecast covid-19 in the usa and japan |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501040/ https://www.ncbi.nlm.nih.gov/pubmed/34625656 http://dx.doi.org/10.1038/s41746-021-00511-7 |
work_keys_str_mv | AT arıksercano aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT shorjoel aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT sinharajarishi aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT yoonjinsung aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT ledsamjosephr aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT lelongt aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT dusenberrymichaelw aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT yodernathanaelc aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT popendorfkris aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT epshteynarkady aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT euphrosinejohan aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT kanalelli aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT jonesisaac aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT lichunliang aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT luanbeth aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT mckennajoe aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT menonvikas aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT singhshashank aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT sunmimi aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT raviashwinsura aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT zhangleyou aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT savadario aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT cunninghamkane aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT kayamahiroki aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT tsaithomas aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT yoneokadaisuke aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT nomurashuhei aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT miyatahiroaki aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT pfistertomas aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT arıksercano prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT shorjoel prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT sinharajarishi prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT yoonjinsung prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT ledsamjosephr prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT lelongt prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT dusenberrymichaelw prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT yodernathanaelc prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT popendorfkris prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT epshteynarkady prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT euphrosinejohan prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT kanalelli prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT jonesisaac prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT lichunliang prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT luanbeth prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT mckennajoe prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT menonvikas prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT singhshashank prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT sunmimi prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT raviashwinsura prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT zhangleyou prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT savadario prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT cunninghamkane prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT kayamahiroki prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT tsaithomas prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT yoneokadaisuke prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT nomurashuhei prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT miyatahiroaki prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan AT pfistertomas prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan |